These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 11208387

  • 41. Association between vitamin D receptor gene polymorphisms and fasting idiopathic hypercalciuria in recurrent stone-forming patients.
    Rendina D, Mossetti G, Viceconti R, Sorrentino M, Castaldo R, Manno G, Guadagno V, Strazzullo P, Nunziata V.
    Urology; 2004 Oct; 64(4):833-8. PubMed ID: 15491743
    [Abstract] [Full Text] [Related]

  • 42. Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population.
    Huang SP, Chou YH, Wayne Chang WS, Wu MT, Chen YY, Yu CC, Wu TT, Lee YH, Huang JK, Wu WJ, Huang CH.
    Cancer Lett; 2004 Apr 15; 207(1):69-77. PubMed ID: 15050735
    [Abstract] [Full Text] [Related]

  • 43. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome.
    Filus A, Trzmiel A, Kuliczkowska-Płaksej J, Tworowska U, Jedrzejuk D, Milewicz A, Medraś M.
    Aging Male; 2008 Sep 15; 11(3):134-9. PubMed ID: 18821289
    [Abstract] [Full Text] [Related]

  • 44. The distribution of two different vitamin D receptor polymorphisms (BsmI and start codon) in primary hyperparathyroidism.
    Sosa M, Torres A, Martín N, Salido E, Limiñana JM, Barrios Y, De Miguel E, Betancor P.
    J Intern Med; 2000 Jan 15; 247(1):124-30. PubMed ID: 10672140
    [Abstract] [Full Text] [Related]

  • 45. Plasma parathyroid hormone, phosphatemia and vitamin D receptor genotype: are they interrelated?
    Chudek J, Karkoszka H, Schmidt-Gayk H, Ritz E, Kokot F.
    J Nephrol; 2000 Jan 15; 13(1):54-8. PubMed ID: 10720215
    [Abstract] [Full Text] [Related]

  • 46. Vitamin D receptor polymorphism and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium.
    Kim HS, Newcomb PA, Ulrich CM, Keener CL, Bigler J, Farin FM, Bostick RM, Potter JD.
    Cancer Epidemiol Biomarkers Prev; 2001 Aug 15; 10(8):869-74. PubMed ID: 11489753
    [Abstract] [Full Text] [Related]

  • 47. Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors.
    Carling T, Rastad J, Akerström G, Westin G.
    J Clin Endocrinol Metab; 1998 Jul 15; 83(7):2255-9. PubMed ID: 9661591
    [Abstract] [Full Text] [Related]

  • 48. Vitamin D receptor alleles b, a, and T: risk factors for sporadic primary hyperparathyroidism (HPT) but not HPT of uremia or MEN 1.
    Carling T, Kindmark A, Hellman P, Holmberg L, Akerström G, Rastad J.
    Biochem Biophys Res Commun; 1997 Feb 13; 231(2):329-32. PubMed ID: 9070272
    [Abstract] [Full Text] [Related]

  • 49. Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.
    Samander EH, Arnold A.
    J Clin Endocrinol Metab; 2006 Dec 13; 91(12):5019-21. PubMed ID: 17003089
    [Abstract] [Full Text] [Related]

  • 50. Vitamin D receptor BsmI and TagI gene polymorphisms in a Turkish ESRD population: influences on parathyroid hormone response.
    Ozdemir FN, Sezer S, Atac B, Tutal E, Verdi H, Sahin F, Haberal M.
    Transplant Proc; 2005 Sep 13; 37(7):2922-4. PubMed ID: 16213262
    [Abstract] [Full Text] [Related]

  • 51. [Association between BsmI vitamin D receptor gene polymorphism and serum concentration of vitamin D with progression of rheumatoid arthritis].
    Milchert M.
    Ann Acad Med Stetin; 2010 Sep 13; 56(1):45-56. PubMed ID: 21433310
    [Abstract] [Full Text] [Related]

  • 52. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
    Correa P, Akerstrom G, Westin G.
    Eur J Endocrinol; 2002 Nov 13; 147(5):671-5. PubMed ID: 12444900
    [Abstract] [Full Text] [Related]

  • 53. Vitamin D receptor polymorphisms correlate to parathyroid cell function in primary hyperparathyroidism.
    Carling T, Ridefelt P, Hellman P, Rastad J, Akerström G.
    J Clin Endocrinol Metab; 1997 Jun 13; 82(6):1772-5. PubMed ID: 9177380
    [Abstract] [Full Text] [Related]

  • 54. Vitamin D receptor levels in colorectal cancer. Possible role of BsmI polymorphism.
    Parisi E, Reñé JM, Cardús A, Valcheva P, Piñol-Felis C, Valdivielso JM, Fernández E.
    J Steroid Biochem Mol Biol; 2008 Jul 13; 111(1-2):87-90. PubMed ID: 18583126
    [Abstract] [Full Text] [Related]

  • 55. BsmI polymorphism of the vitamin D receptor gene in hyperparathyroid or hypoparathyroid dialysis patients.
    Tagliabue J, Farina M, Imbasciati E, Vergani C, Annoni G.
    Am J Clin Pathol; 1999 Sep 13; 112(3):366-70. PubMed ID: 10478142
    [Abstract] [Full Text] [Related]

  • 56. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
    Varshney S, Bhadada SK, Sachdeva N, Arya AK, Saikia UN, Behera A, Rao SD.
    J Clin Endocrinol Metab; 2013 Oct 13; 98(10):E1631-5. PubMed ID: 23913941
    [Abstract] [Full Text] [Related]

  • 57. Vitamin D receptor genotypes in primary hyperparathyroidism.
    Carling T, Kindmark A, Hellman P, Lundgren E, Ljunghall S, Rastad J, Akerström G, Melhus H.
    Nat Med; 1995 Dec 13; 1(12):1309-11. PubMed ID: 7489414
    [Abstract] [Full Text] [Related]

  • 58. Parathyroid hormone gene polymorphisms in primary hyperparathyroidism.
    Kanzawa M, Sugimoto T, Kobayashi T, Kobayashi A, Chihara K.
    Clin Endocrinol (Oxf); 1999 May 13; 50(5):583-8. PubMed ID: 10468923
    [Abstract] [Full Text] [Related]

  • 59. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis.
    Sudhaker Rao D, Han ZH, Phillips ER, Palnitkar S, Parfitt AM.
    Clin Endocrinol (Oxf); 2000 Sep 13; 53(3):373-81. PubMed ID: 10971456
    [Abstract] [Full Text] [Related]

  • 60. Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure.
    Fernández E, Fibla J, Betriu A, Piulats JM, Almirall J, Montoliu J.
    J Am Soc Nephrol; 1997 Oct 13; 8(10):1546-52. PubMed ID: 9335382
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.